Suscriptores   Asóciese  
Textos Completos Autorizados
TRASPLANTE DE CELULAS MADRE PARA REGENERAR Y ASISTIR EL CORAZON

v-estudie-lo-mejor.gif
Expertos Invitados





TRASPLANTE DE CELULAS MADRE PARA REGENERAR Y ASISTIR EL CORAZON

(especial para SIIC © Derechos reservados)
La medicina regenerativa comenzó a desarrollarse gracias a las recientes innovaciones en el dominio de la biología celular (aplicacion de células madre multipotentes) y a otras disciplinas como la ingenieria de tejidos, bioquimica, biofisica, genética y biología molecular. El trasplante de células progenitoras indiferenciadas en el miocardio patologico regenera las células cardíacas y su matriz extracelular a través de mecanismos de “angiogénesis” y “miogénesis”. El objetivo de las técnicas de regeneración es el restablecimiento de la estructura y función de tejidos lesionados, la finalidad principal es evitar el trasplante de órganos.
Autor:
Jc Chacques
Columnista Experto de SIIC

Institución:
Department of Cardiovascular Surgery, European Hospital Georges Pompidou

Artículos publicados por Jc Chacques
Coautor
Juan Carlos Chachques* 
Md, Phd, Hospital Europeo Georges Pompidou, Cirujano, Director de Investigaciones*
Aprobación
3 de Febrero, 2006 		Primera edición
21 de Septiembre, 2006 		Segunda edición, ampliada y corregida
7 de Junio, 2021

TRASPLANTE DE CELULAS MADRE PARA REGENERAR Y ASISTIR EL CORAZON


Artículo completo
(castellano)
Extensión:  +/-3.24 páginas impresas en papel A4
Exclusivo para suscriptores/assinantes
Clasificación en siicsalud
Artículos originales > Expertos del Mundo >
página   www.siicsalud.com/des/expertocompleto.php/

Especialidades
Principal: Cardiología, Cirugía
Relacionadas: Anatomía Patológica, Cuidados Intensivos, Medicina Interna, Trasplantes



Comprar este artículo
Extensión: 3.24 páginas impresas en papel A4

file05.gif (1491 bytes) Artículos seleccionados para su compra



Bibliografía del artículo
1. Chachques JC, Shafy A, Duarte F, Cattadori B, Goussef N, Shen L, et al. From dynamic to cellular cardiomyoplasty. J Card Surg 2002; 17:194-200.
2. Di Donato M, Toso A, Dor V, Sabatier M, Barletta G, Menicanti L, et al; RESTORE Group. Surgical ventricular restoration improves mechanical intraventricular dyssynchrony in ischemic cardiomyopathy. Circulation 2004; 109:2536-43.
3. Benicio A, Moreira LF, Bacal F, Stolf NA, Oliveira SA. Reevaluation of long-term outcomes of dynamic cardiomyoplasty. Ann Thorac Surg 2003; 76:821-7.
4. Haider HKh, Tan AC, Aziz S, Chachques JC, Sim EK. Myoblast transplantation for cardiac repair: a clinical perspective. Mol Ther 2004; 9:14-23.
5. Chiu RC. Therapeutic cardiac angiogenesis and myogenesis: the promises and challenges on a new frontier. J Thorac Cardiovasc Surg 2001; 122:851-2.
6. El Oakley RM, Ooi OC, Bongso A, Yacoub MH. Myocyte transplantation for myocardial repair: a few good cells can mend a broken heart. Ann Thorac Surg 2001; 71:1724-33.
7. Chiu RC, Zibaitis A, Kao RL. Cellular cardiomyoplasty: myocardial regeneration with satellite cell implantation. Ann Thorac Surg 1995; 60:12-8.
8. Tang GH, Fedak PW, Yau TM, Weisel RD, Kulik A, Mickle DA, et al. Cell transplantation to improve ventricular function in the failing heart. Eur J Cardiothorac Surg 2003; 23:907-16.
9. Law PK. Myoblast transplantation. Science 1992; 257:1329-30.
10. Rajnoch C, Chachques JC, Berrebi A, Bruneval P, Benoit MO, Carpentier A. Cellular therapy reverses myocardial dysfunction. J Thorac Cardiovasc Surg 2001; 121:871-8.
11. Sim EK, Jiang S, Ye L, Lim YL, Ooi OC, Haider KH. Skeletal myoblast transplant in heart failure. J Card Surg 2003; 18:319-27.
12. Tambara K, Sakakibara Y, Sakaguchi G, Lu F, Premaratne GU, Lin X, et al. Transplanted skeletal myoblasts can fully replace the infarcted myocardium when they survive in the host in large numbers. Circulation 2003; 108(Suppl 1):II259-63.
13. Chachques JC, Cattadori B, Herreros J, Prosper F, Trainini JC, Blanchard D, et al. Treatment of heart failure with autologous skeletal myoblasts. Herz 2002; 27:570-8.
14. Yau TM, Tomita S, Weisel RD, Jia ZQ, Tumiati LC, Mickle DA, et al. Beneficial effect of autologous cell transplantation on infarcted heart function: comparison between bone marrow stromal cells and heart cells. Ann Thorac Surg 2003; 75:169-177.
15. Fujii T, Yau TM, Weisel RD, Ohno N, Mickle DA, Shiono N, et al. Cell transplantation to prevent heart failure: a comparison of cell types. Ann Thorac Surg 2003; 76:2062-70.
16. Bittira B, Kuang JQ, Al-Khaldi A, Shum-Tim D, Chiu RC. In vitro preprogramming of marrow stromal cells for myocardial regeneration. Ann Thorac Surg 2002; 74:1154-60.
17. Stamm C, Westphal B, Kleine HD, Petzsch M, Kittner C, Klinge H, et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 2003; 361:45-6.
18. He JQ, Ma Y, Lee Y, Thomson JA, Kamp TJ. Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization. Circ Res 2003; 93:32-9.
19. Lanza R, Moore MA, Wakayama T, Perry AC, Shieh JH, Hendrikx J, et al. Regeneration of the infarcted heart with stem cells derived by nuclear transplantation. Circ Res 2004; 94:820-7.
20. Elmadbouh I, Chen Y, Louedec L, Osborne-Pellegrin M, Silberman S, Meilhac O, et al. Mesothelial cell transplantation in the post-myocardial infarct scar induces angiogenesis and improves heart function. Circulation 2004; 110 (Suppl. III): 303 (abstract).
21. Planat-Benard V, Silvestre JS, Cousin B, Andre M, Nibbelink M, Tamarat R, et al. Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation 2004; 109:656-63.
22. Planat-Benard V, Menard C, Andre M, Puceat M, Perez A, Garcia-Verdugo JM, et al. Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells. Circ Res 2004; 94:223-9.
23. Nosrat IV, Smith CA, Mullally P, Olson L, Nosrat CA. Dental pulp cells provide neurotrophic support for dopaminergic neurons and differentiate into neurons in vitro; implications for tissue engineering and repair in the nervous system. Eur J Neurosci 2004; 19:2388-98.
24. Norol F, Merlet P, Isnard R, Sebillon P, Bonnet N, Cailliot C, et al. Influence of mobilized stem cells on myocardial infarct repair in a nonhuman primate model. Blood 2003; 102:4361-8.
25. Matsubara H. Risk to the coronary arteries of intracoronary stem cell infusion and G-CSF cytokine therapy. Lancet 2004; 363:746-7.
26. Chachques JC, Acar C, Herreros J, Trainini J, Prosper F, D\'Attellis N, et al. Cellular cardiomyoplasty: clinical application. Ann Thorac Surg 2004; 77:1121-30.
27. Vilas-Boas F, Feitosa GS, Soares MB, Pinho-Filho JA, Mota A, Almeida AJ, et al. Bone marrow cell transplantation to the myocardium of a patient with heart failure due to Chagas' disease. Arq Bras Cardiol 2004; 82:185-7, 181-4.
28. Chachques JC, Duarte F, Cattadori B, Shafy A, Lila N, Chatellier G, et al. Angiogenic growth factors and/or cellular therapy for myocardial regeneration: a comparative study. J Thorac Cardiovasc Surg 2004; 128:245-53.
29. Thompson RB, Parsa CJ, Van den Bos EJ, Davis BH, Toloza EM, Klem I, et al. Video-assisted thoracoscopic transplantation of myoblasts into the heart. Ann Thorac Surg 2004; 78:303-7.
30. Strauer BE, Brehm M, Zeus T, Kostering M, Hernandez A, Sorg RV, et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002; 106:1913-8.
31. Assmus B, Schächinger V, Teupe C, Britten M, Lehmann R, Dobert N, et al. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation 2002; 106:3009-17.
32. Vulliet PR, Greeley M, Halloran SM, MacDonald KA, Kittleson MD. Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. Lancet 2004; 363:783-4.
33. Herreros J, Prosper F, Perez A, Gavira JJ, Garcia-Velloso MJ, Barba J, et al. Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction. Eur Heart J 2003; 24:2012-20.
34. Trainini JC, Lago N, De Paz J, Cichero D, Giordano R, Mouras J, et al. Myoblast transplantation for myocardial repair: a clinical case. J Heart Lung Transplant 2004; 23:503-5.
35. Menasche P, Hagege AA, Vilquin JT, Desnos M, Abergel E, Pouzet B, et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 2003; 41:1078-83.
36. Smits PC, van Geuns RJ, Poldermans D, Bountioukos M, Onderwater EE, Lee CH, et al. Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up. J Am Coll Cardiol 2003; 42:2063-9.
37. Hamano K, Nishida M, Hirata K, Mikamo A, Li TS, Harada M, et al. Local implantation of autologous bone marrow cells for therapeutic angiogenesis in patients with ischemic heart disease: clinical trial and preliminary results. Jpn Circ J 2001; 65:845-7.
38. Tse HF, Kwong YL, Chan JK, Lo G, Ho CL, Lau CP. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 2003; 361:47-9.
39. Zhang F, Yang Z, Chen Y, Qin J, Zhu T, Xu D, et al. Clinical cellular cardiomyoplasty: technical considerations. J Card Surg 2003; 18:268-73.
40. Pagani FD, DerSimonian H, Zawadzka A, Wetzel K, Edge AS, Jacoby DB, et al. Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. J Am Coll Cardiol 2003; 41:879-88.
41. Fuchs S, Satler LF, Kornowski R, Okubagzi P, Weisz G, Baffour R, et al. Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease: a feasibility study. J Am Coll Cardiol 2003; 41:1721-4.
42. Perin EC, Dohmann HF, Borojevic R, Silva SA, Sousa AL, Mesquita CT, et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 2003; 107:2294-302.
43. Chachques JC. Method of providing a dynamic cellular cardiac support. US patents A2002 0124855 and A2005 0002912 (see http://www.uspto.gov)
44. Chachques JC, Shafy A, Cattadori B, Duarte F, Shen L, Meimoun P, et al. Electrostimulation enhanced fatigue resistant myosin expression in cellular cardiomyoplasty. Circulation. 2001; 104(Suppl 2):555-6 (abstract).
45. Chachques JC, Herreros J, Trainini J, Juffe A, Rendal E, Prosper F, et al. Autologous human serum for cell culture avoids the implantation of cardioverter-defibrillators in cellular cardiomyoplasty. Int J Cardiol 2004; 95 (Suppl 1):S29-33.
46. Chachques JC, Herreros J, Lorusso R. New “Cell-Fix” catheter for infarct detection and cell delivery. Int J Cardiol. 2004; 95 (Suppl 1):S70 (abstract).
47. Taylor DA, Hruban R, Rodriguez ER, Goldschmidt-Clermont PJ. Cardiac chimerism as a mechanism for self-repair: does it happen and if so to what degree? Circulation 2002; 106:2-4.
48. Hocht-Zeisberg E, Kahnert H, Guan K, Wulf G, Hemmerlein B, Schlott T, et al. Cellular repopulation of myocardial infarction in patients with sex-mismatched heart transplantation. Eur Heart J 2004; 25:749-58.
49. Ohno N, Fedak PW, Weisel RD, Komeda M, Mickle DA, Li RK. Cell transplantation in non-ischemic dilated cardiomyopathy. A novel biological approach for ventricular restoration. Jpn J Thorac Cardiovasc Surg 2002; 50:457-60.
50. Miyagawa S, Sawa Y, Taketani S, Kawaguchi N, Nakamura T, Matsuura N, et al. Myocardial regeneration therapy for heart failure: hepatocyte growth factor enhances the effect of cellular cardiomyoplasty. Circulation 2002; 105:2556-61.
51. Retuerto MA, Schalch P, Patejunas G, Carbray J, Liu N, Esser K, et al. Angiogenic pretreatment improves the efficacy of cellular cardiomyoplasty performed with fetal cardiomyocyte implantation. J Thorac Cardiovasc Surg 2004; 127:1041-51.
52. Murry CE, Soonpaa MH, Reinecke H, Nakajima H, Nakajima HO, Rubart M, et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004; 428:664-8.
53. Iijima Y, Nagai T, Mizukami M, Matsuura K, Ogura T, Wada H, et al. Beating is necessary for transdifferentiation of skeletal muscle-derived cells into cardiomyocytes. FASEB J 2003; 17:1361-3.
54. Ott HC, Bonaros N, Marksteiner R, Wolf D, Margreiter E, Schachner T, et al. Combined transplantation of skeletal myoblasts and bone marrow stem cells for myocardial repair in rats. Eur J Cardiothorac Surg 2004; 25:627-34.
55. Carvalho KA, Guarita-Souza LC, Rebelatto CL, Senegaglia AC, Hansen P, Mendonca JG, et al. Could the coculture of skeletal myoblasts and mesenchymal stem cells be a solution for postinfarction myocardial scar? Transplant Proc 2004; 36:991-2.
56. McDevitt TC, Woodhouse KA, Hauschka SD, Murry CE, Stayton PS. Spatially organized layers of cardiomyocytes on biodegradable polyurethane films for myocardial repair. J Biomed Mater Res A 2003; 66:586-95.
Título español
 Bibliografía
 Artículo completo
(exclusivo a suscriptores)
 Autoevaluación
  Tema principal en SIIC Data Bases
 Especialidades

  English title
  Abstract
  Key words
Full text
(exclusivo a suscriptores)

Autor 
Artículos
Correspondencia

Patrocinio y reconocimiento
Imprimir esta página
 
 
 
 
 
 
 
 
 
 
 
 
Está expresamente prohibida la redistribución y la redifusión de todo o parte de los contenidos de la Sociedad Iberoamericana de Información Científica (SIIC) S.A. sin previo y expreso consentimiento de SIIC.
ua31618
Acerca de SIIC   Estructura de SIIC   Fuentes informativas  

Sociedad Iberoamericana de Información Científica

Copyright siicsalud© 1997-2024 ISSN siicsalud: 1667-9008
ua31517